BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 24639548)

  • 1. Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.
    Caizzi L; Ferrero G; Cutrupi S; Cordero F; Ballaré C; Miano V; Reineri S; Ricci L; Friard O; Testori A; Corà D; Caselle M; Di Croce L; De Bortoli M
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4892-7. PubMed ID: 24639548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancer.
    Miano V; Ferrero G; Reineri S; Caizzi L; Annaratone L; Ricci L; Cutrupi S; Castellano I; Cordero F; De Bortoli M
    Oncotarget; 2016 Jan; 7(3):3201-16. PubMed ID: 26621851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
    Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
    Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells.
    Erdős E; Bálint BL
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32168782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions.
    Jehanno C; Percevault F; Boujrad N; Le Goff P; Fontaine C; Arnal JF; Primig M; Pakdel F; Michel D; Métivier R; Flouriot G
    Mol Cell Endocrinol; 2021 Jun; 530():111282. PubMed ID: 33894309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z; Reierstad S; Huang CC; Bulun SE
    Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells.
    Cardamone MD; Bardella C; Gutierrez A; Di Croce L; Rosenfeld MG; Di Renzo MF; De Bortoli M
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7420-5. PubMed ID: 19383788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state.
    Kong SL; Li G; Loh SL; Sung WK; Liu ET
    Mol Syst Biol; 2011 Aug; 7():526. PubMed ID: 21878914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
    Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
    Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.
    Frietze S; O'Geen H; Littlepage LE; Simion C; Sweeney CA; Farnham PJ; Krig SR
    BMC Genomics; 2014 Jun; 15(1):520. PubMed ID: 24962896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research resource: whole-genome estrogen receptor α binding in mouse uterine tissue revealed by ChIP-seq.
    Hewitt SC; Li L; Grimm SA; Chen Y; Liu L; Li Y; Bushel PR; Fargo D; Korach KS
    Mol Endocrinol; 2012 May; 26(5):887-98. PubMed ID: 22446102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.
    Stender JD; Stossi F; Funk CC; Charn TH; Barnett DH; Katzenellenbogen BS
    Mol Endocrinol; 2011 Oct; 25(10):1699-709. PubMed ID: 21868451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
    Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
    Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
    Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.
    Need EF; Selth LA; Harris TJ; Birrell SN; Tilley WD; Buchanan G
    Mol Endocrinol; 2012 Nov; 26(11):1941-52. PubMed ID: 23023562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.